154 related articles for article (PubMed ID: 27187348)
1. Synthesis and Biological Evaluation of Benzochromenopyrimidinones as Cholinesterase Inhibitors and Potent Antioxidant, Non-Hepatotoxic Agents for Alzheimer's Disease.
Dgachi Y; Bautista-Aguilera OM; Benchekroun M; Martin H; Bonet A; Knez D; Godyń J; Malawska B; Gobec S; Chioua M; Janockova J; Soukup O; Chabchoub F; Marco-Contelles J; Ismaili L
Molecules; 2016 May; 21(5):. PubMed ID: 27187348
[TBL] [Abstract][Full Text] [Related]
2. Imidazopyranotacrines as Non-Hepatotoxic, Selective Acetylcholinesterase Inhibitors, and Antioxidant Agents for Alzheimer's Disease Therapy.
Boulebd H; Ismaili L; Bartolini M; Bouraiou A; Andrisano V; Martin H; Bonet A; Moraleda I; Iriepa I; Chioua M; Belfaitah A; Marco-Contelles J
Molecules; 2016 Mar; 21(4):400. PubMed ID: 27023499
[TBL] [Abstract][Full Text] [Related]
3. Tetrahydropyranodiquinolin-8-amines as new, non hepatotoxic, antioxidant, and acetylcholinesterase inhibitors for Alzheimer's disease therapy.
Dgachi Y; Sokolov O; Luzet V; Godyń J; Panek D; Bonet A; Martin H; Iriepa I; Moraleda I; García-Iriepa C; Janockova J; Richert L; Soukup O; Malawska B; Chabchoub F; Marco-Contelles J; Ismaili L
Eur J Med Chem; 2017 Jan; 126():576-589. PubMed ID: 27918993
[TBL] [Abstract][Full Text] [Related]
4. New (benz)imidazolopyridino tacrines as nonhepatotoxic, cholinesterase inhibitors for Alzheimer disease.
Boulebd H; Ismaili L; Martin H; Bonet A; Chioua M; Marco Contelles J; Belfaitah A
Future Med Chem; 2017 May; 9(8):723-729. PubMed ID: 28485637
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and biological assessment of racemic benzochromenopyrimidinetriones as promising agents for Alzheimer's disease therapy.
Dgachi Y; Martin H; Bonet A; Chioua M; Iriepa I; Moraleda I; Chabchoub F; Marco-Contelles J; Ismaili L
Future Med Chem; 2017 May; 9(8):715-721. PubMed ID: 28504912
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and Biological Assessment of Racemic Benzochromenopyrimidinimines as Antioxidant, Cholinesterase, and Aβ1-42 Aggregation Inhibitors for Alzheimer's Disease Therapy.
Dgachi Y; Ismaili L; Knez D; Benchekroun M; Martin H; Szałaj N; Wehle S; Bautista-Aguilera OM; Luzet V; Bonnet A; Malawska B; Gobec S; Chioua M; Decker M; Chabchoub F; Marco-Contelles J
ChemMedChem; 2016 Jun; 11(12):1318-27. PubMed ID: 26804623
[TBL] [Abstract][Full Text] [Related]
7. Design, Synthesis and in vitro Evaluation of Indolotacrine Analogues as Multitarget-Directed Ligands for the Treatment of Alzheimer's Disease.
Benek O; Soukup O; Pasdiorova M; Hroch L; Sepsova V; Jost P; Hrabinova M; Jun D; Kuca K; Zala D; Ramsay RR; Marco-Contelles J; Musilek K
ChemMedChem; 2016 Jun; 11(12):1264-9. PubMed ID: 26427608
[TBL] [Abstract][Full Text] [Related]
8. Design, synthesis, and biological evaluation of 2-arylethenylquinoline derivatives as multifunctional agents for the treatment of Alzheimer's disease.
Wang XQ; Xia CL; Chen SB; Tan JH; Ou TM; Huang SL; Li D; Gu LQ; Huang ZS
Eur J Med Chem; 2015 Jan; 89():349-61. PubMed ID: 25462251
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and evaluation of multi-target-directed ligands for the treatment of Alzheimer's disease based on the fusion of donepezil and melatonin.
Wang J; Wang ZM; Li XM; Li F; Wu JJ; Kong LY; Wang XB
Bioorg Med Chem; 2016 Sep; 24(18):4324-4338. PubMed ID: 27460699
[TBL] [Abstract][Full Text] [Related]
10. Pterostilbene-O-acetamidoalkylbenzylamines derivatives as novel dual inhibitors of cholinesterase with anti-β-amyloid aggregation and antioxidant properties for the treatment of Alzheimer's disease.
Li Y; Qiang X; Li Y; Yang X; Luo L; Xiao G; Cao Z; Tan Z; Deng Y
Bioorg Med Chem Lett; 2016 Apr; 26(8):2035-9. PubMed ID: 26947607
[TBL] [Abstract][Full Text] [Related]
11. Benzylpiperidine-Linked Diarylthiazoles as Potential Anti-Alzheimer's Agents: Synthesis and Biological Evaluation.
Shidore M; Machhi J; Shingala K; Murumkar P; Sharma MK; Agrawal N; Tripathi A; Parikh Z; Pillai P; Yadav MR
J Med Chem; 2016 Jun; 59(12):5823-46. PubMed ID: 27253679
[TBL] [Abstract][Full Text] [Related]
12. Donepezil-butylated hydroxytoluene (BHT) hybrids as Anti-Alzheimer's disease agents with cholinergic, antioxidant, and neuroprotective properties.
Cai P; Fang SQ; Yang HL; Yang XL; Liu QH; Kong LY; Wang XB
Eur J Med Chem; 2018 Sep; 157():161-176. PubMed ID: 30096650
[TBL] [Abstract][Full Text] [Related]
13. Exploiting the lipoic acid structure in the search for novel multitarget ligands against Alzheimer's disease.
Rosini M; Simoni E; Bartolini M; Tarozzi A; Matera R; Milelli A; Hrelia P; Andrisano V; Bolognesi ML; Melchiorre C
Eur J Med Chem; 2011 Nov; 46(11):5435-42. PubMed ID: 21924801
[TBL] [Abstract][Full Text] [Related]
14. Discovery of Novel Pyrazolopyrimidinone Derivatives as Phosphodiesterase 9A Inhibitors Capable of Inhibiting Butyrylcholinesterase for Treatment of Alzheimer's Disease.
Yu YF; Huang YD; Zhang C; Wu XN; Zhou Q; Wu D; Wu Y; Luo HB
ACS Chem Neurosci; 2017 Nov; 8(11):2522-2534. PubMed ID: 28783948
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and evaluation of dihydropyrimidinone-derived selenoesters as multi-targeted directed compounds against Alzheimer's disease.
Barbosa FAR; Canto RFS; Saba S; Rafique J; Braga AL
Bioorg Med Chem; 2016 Nov; 24(22):5762-5770. PubMed ID: 27681239
[TBL] [Abstract][Full Text] [Related]
16. Design, synthesis and evaluation of novel 5,6,7-trimethoxyflavone-6-chlorotacrine hybrids as potential multifunctional agents for the treatment of Alzheimer's disease.
Liao S; Deng H; Huang S; Yang J; Wang S; Yin B; Zheng T; Zhang D; Liu J; Gao G; Ma J; Deng Z
Bioorg Med Chem Lett; 2015 Apr; 25(7):1541-5. PubMed ID: 25724825
[TBL] [Abstract][Full Text] [Related]
17. Novel tacrine-grafted Ugi adducts as multipotent anti-Alzheimer drugs: a synthetic renewal in tacrine-ferulic acid hybrids.
Benchekroun M; Bartolini M; Egea J; Romero A; Soriano E; Pudlo M; Luzet V; Andrisano V; Jimeno ML; López MG; Wehle S; Gharbi T; Refouvelet B; de Andrés L; Herrera-Arozamena C; Monti B; Bolognesi ML; Rodríguez-Franco MI; Decker M; Marco-Contelles J; Ismaili L
ChemMedChem; 2015 Mar; 10(3):523-39. PubMed ID: 25537267
[TBL] [Abstract][Full Text] [Related]
18. Synthesis, biological assessment, and molecular modeling of racemic 7-aryl-9,10,11,12-tetrahydro-7H-benzo[7,8]chromeno[2,3-b]quinolin-8-amines as potential drugs for the treatment of Alzheimer's disease.
Maalej E; Chabchoub F; Oset-Gasque MJ; Esquivias-Pérez M; González MP; Monjas L; Pérez C; de los Ríos C; Rodríguez-Franco MI; Iriepa I; Moraleda I; Chioua M; Romero A; Marco-Contelles J; Samadi A
Eur J Med Chem; 2012 Aug; 54():750-63. PubMed ID: 22795665
[TBL] [Abstract][Full Text] [Related]
19. Design, Synthesis, Biological Evaluation, and Docking Study of Acetylcholinesterase Inhibitors: New Acridone-1,2,4-oxadiazole-1,2,3-triazole Hybrids.
Mohammadi-Khanaposhtani M; Mahdavi M; Saeedi M; Sabourian R; Safavi M; Khanavi M; Foroumadi A; Shafiee A; Akbarzadeh T
Chem Biol Drug Des; 2015 Dec; 86(6):1425-32. PubMed ID: 26077890
[TBL] [Abstract][Full Text] [Related]
20. Novel deoxyvasicinone derivatives as potent multitarget-directed ligands for the treatment of Alzheimer's disease: Design, synthesis, and biological evaluation.
Ma F; Du H
Eur J Med Chem; 2017 Nov; 140():118-127. PubMed ID: 28923380
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
